Yaolin Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yaolin Zhang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Chunfang Ha
Department of Gynecology General Hospital of Ningxia Medical University No. 804, Shengli Street Yinchuan Ningxia Hui Autonomous Region 750003 China
1 shared publicationGuiyi Ji
Department of Reproductive Medicine General Hospital of Ningxia Medical University (The First Clinical Medical College of Ningxia Medical University) No. 804, Shengli Street Yinchuan Ningxia Hui Autonomous Region 750003 China
1 shared publication- Heng Fan
Ningxia Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, China
1 shared publication Jianli Song
Department of Reproductive Medicine General Hospital of Ningxia Medical University (The First Clinical Medical College of Ningxia Medical University) No. 804, Shengli Street Yinchuan Ningxia Hui Autonomous Region 750003 China
1 shared publicationJing Wang
Ningxia Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Sciences General Hospital of Ningxia Medical University No. 804, Shengli Street Yinchuan Ningxia Hui Autonomous Region 750003 China
1 shared publication- Rong Hu
Reproductive Medicine Center, General Hospital of Ningxia Medical University
1 shared publication
Latest Publications
- Open Access
- 23 September 2025
- Published by Wiley in Advanced Science
- Vol. 12 (48) , e08240
Hepatic KLF9 Deficiency Inhibits Dehydroepiandrosterone (DHEA)‐Induced Polycystic Ovary Syndrome via Liver‐Ovary Axis
Hyperandrogenism is one of the key leading causes of polycystic ovary syndrome (PCOS), which is a complex metabolic disorder affecting 6% to 20% of women of reproductive age. However, the molecular pathogenetic mechanisms responsible for androgen excess in PCOS remain largely unknow. While most previous studies have specifically focused on ovarian tissue, few have evaluated the role of extraovarian organs in PCOS. Here, it is found that KLF9 expression is up‐regulated in murine primary hepatocytes treated with DHEA. Notably, the genetic ablation of Klf9 in hepatocytes significantly alleviated the progression of DHEA induced PCOS in mouse. Conversely, hepatic Klf9 transgenic mice displayed a spontaneous PCOS‐like phenotype. Mechanistically, hepatic KLF9 is directly activated by intranuclear AR and then directly binds to the promoter of Srd5a1 and the gene loci of Hsd3b3 , which encode the enzyme for the conversion of DHEA to dihydrotestosterone, to promote its transcription in the liver. Overall, our study indicated that the liver plays a vital role in the development of PCOS and that hepatic KLF9 might be a potential therapeutic target for PCOS.
- 23 September 2025
- Published by Wiley in Advanced Science
- Vol. 12 (48) , e08240
Open AccessHepatic KLF9 Deficiency Inhibits Dehydroepiandrosterone (DHEA)‐Induced Polycystic Ovary Syndrome via Liver‐Ovary Axis
Hyperandrogenism is one of the key leading causes of polycystic ovary syndrome (PCOS), which is a complex metabolic disorder affecting 6% to 20% of women of reproductive age. However, the molecular pathogenetic mechanisms responsible for androgen excess in PCOS remain largely unknow. While most previous studies have specifically focused on ovarian tissue, few have evaluated the role of extraovarian organs in PCOS. Here, it is found that KLF9 expression is up‐regulated in murine primary hepatocytes treated with DHEA. Notably, the genetic ablation of Klf9 in hepatocytes significantly alleviated the progression of DHEA induced PCOS in mouse. Conversely, hepatic Klf9 transgenic mice displayed a spontaneous PCOS‐like phenotype. Mechanistically, hepatic KLF9 is directly activated by intranuclear AR and then directly binds to the promoter of Srd5a1 and the gene loci of Hsd3b3 , which encode the enzyme for the conversion of DHEA to dihydrotestosterone, to promote its transcription in the liver. Overall, our study indicated that the liver plays a vital role in the development of PCOS and that hepatic KLF9 might be a potential therapeutic target for PCOS.
- 5 August 2023
- Published by Springer Nature
- p. 1602-1614
Game Engine-Based Synthetic Dataset Generation of Entities on Construction Site
- 5 August 2023
- Published by Springer Nature
- p. 1602-1614
Game Engine-Based Synthetic Dataset Generation of Entities on Construction Site